Mumbai, Jan. 31 -- Sun Pharmaceutical Industries Ltd officially stated here on Saturday that it has posted a 16% year-on-year (YoY) increase in its Q3FY26 net profit at Rs 3,368.8 crore as compared to its Rs 2,903 crore net profit in the same period last year.
The company's board has declared an interim dividend of Rs 11 per equity share of Rs 1 each for FY26. The record date for the dividend is set for February 5, 2026, and the payout will be made on or before February 16, 2026.
Revenue from operations rose 13.5% year-on-year to Rs 15,520.5 crore, surpassing Street estimates of Rs 14,874.7 crore. Sales for the quarter stood at Rs 15,469.1 crore, marking a 15.1% increase from the year-ago period.
Sun Pharma's operating performance also b...